Breakthrough method turns ‘cold’ tumors into immune targets, raising hope for lasting cancer control - Anadolu Ajansı ...

Scientists have found a way to transform hard-to-treat tumors into targets for the immune system. Using two protein ...

B cells are thought to play a critical role in innate and adaptive immunity, but their exact role in anti-tumor immunity remains unknown. Researchers with expertise in immunology collaborated with ...

The Kawasaki Innovation Center for NanoMedicine (iCONM; Director: Kazunori Kataoka; Location: Kawasaki, Japan) have announced with Tokyo Medical and Dental University, and Kyorin University that a ...

This form of immunity is non discriminatory; it is not directed against specific pathogens, but just about anything that enters the body that is foreign. Vertebrates have another more sophisticated ...

Disparities in multiple myeloma: A global perspective on drug toxicity trends. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a full text ...

Breast cancer (BRCA) remains the most common malignant cancer in women worldwide. Although a range of treatments exists, ...

Qivigy (immune globulin intravenous, human-kthm) is a ready-to-use, sterile, non-pyrogenic liquid solution of human immune globulin for IV administration.

The FDA has approved Kedrion Biopharma’s Qivigy, a 10% IV immunoglobulin therapy, for treating adults who have primary ...